Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Stolper Mark, Director. Director active across 3 companies, notably Surgalign Holdings, INC.. Cumulatively, 15 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €3.6m. History available since 7 May 2021. The latest transaction was filed on 27 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stolper Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
STOLPER MARK is an Administrateur and has made 15 filings in total. Among the 15 sampled recent filings, the period covered runs from 2016-01-05 to 2026-07-29, with 0 in buys and 3601465 in sales, mainly in RadNet, Inc., as well as filings for Surgalign Holdings, INC. and Oncology Institute, Inc.; the modal transaction nature is Attribution.